ISPE names 2026 FOYA winners, including AstraZeneca, Takeda, Bayer, and more, recognized for innovation, sustainability, and ...
Explore how modular facilities and single-use technologies enable scalable, compliant biomanufacturing for global commercial ...
Acumetis, formed by merging five firms, offers strategic support for life sciences, with 350 experts across 50+ markets and ...
The US Pharmacopeia highlights risks of Red Sea trade disruptions, impacting US drug supplies, with 73% of flumazenil APIs ...
Regeneron and Telix join forces in a 50/50 collaboration to develop and commercialize next-gen radiopharmaceuticals, ...
This webinar explores an integrated approach to mAb development that embeds manufacturability, scalability, lifecycle ...
Plasmid DNA is critical for cell and gene therapies, but scaling high-purity production remains challenging as CDMO partners ...
Middle East conflict disrupts pharma supply chains, raising costs and risking shortages of key medicines globally.
Aragen unveils ChemiSHE, a woman-led lab in Hyderabad, aiming to boost gender diversity with 800+ hires in science and ...
Despite persistent cost concerns, continued innovation is reinforcing the chromatography resin market’s long-term growth.
RT-MALS can provide instantaneous measurements of adenovirus particle size and titer during downstream and fill–finish ...
Emerging pathways can help cell and gene therapies become commercially viable for intractable diseases, even with uneven scalability and consistency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results